Diamyd Medical prepares GMP-production of GABA
Diamyd Medical announced today that a first amount of GABA has been produced and that the manufacturing process is to be scaled up for GMP production. The Company also highlights that two recently published scientific articles support GABA's relevance in the treatment of diabetes.Diamyd Medical has, as previously reported, expanded its operations to include type 2 diabetes and rheumatoid arthritis, where a significant part of the development plan is manufacturing of a proprietary GABA drug product. Diamyd Medical has during the autumn visited its selected manufacturer. GABA synthesis and